Skip to content
View in the app

A better way to browse. Learn more.

Thailand News and Discussion Forum | ASEANNOW

A full-screen app on your home screen with push notifications, badges and more.

To install this app on iOS and iPadOS
  1. Tap the Share icon in Safari
  2. Scroll the menu and tap Add to Home Screen.
  3. Tap Add in the top-right corner.
To install this app on Android
  1. Tap the 3-dot menu (⋮) in the top-right corner of the browser.
  2. Tap Add to Home screen or Install app.
  3. Confirm by tapping Install.

Top Virologist Recommends Using Thai LAAB Supplies

Featured Replies

ccebea67f1b01e745a5fd41a273018fa_small.jpeg

 

BANGKOK (NNT) - Thailand’s top virologist has commented on the use of antibodies to treat COVID-19 in immunocompromised patients. He suggested that the long-acting antibodies (LAABs) already available in the kingdom should be utilized during the current wave of COVID outbreaks. The effectiveness of the LAABs in stock is expected to only decline as the coronavirus mutates further.

 

Dr Yong Poovorawan, a virology expert at Chulalongkorn University’s Faculty of Medicine, explained that antibodies were used during the early stages of the pandemic. COVID vaccines were not available at the time and so plasma from recovered patients, which contained antibodies, were used to treat new patients. With the development of proper vaccines that trigger antibody production in recipients, there was no longer a need for plasma treatment.

 

Dr Yong, who heads the university’s Center of Excellence in Clinical Virology, wrote that continuous viral mutations make manufactured antibodies less effective. With Omicron BA.2.75 being the current dominant strain, the most effective antibodies available in Thailand are those acquired under the LAAB procurement scheme. Dr Yong added that current LAABs will become even less effective as the virus mutates further and as sub-variants of the BQ.1, BQ.1.1 or XBB strains become widespread.

 

The virologist is recommending that antibodies be given to patients with weak immune systems, such as those with chronic kidney failure, people on immunosuppressants, organ transfer patients and cancer patients undergoing certain stages of treatment.

 

Dr Yong wrote that LAABs can be used to treat members of vulnerable groups who have not received sufficient vaccine injections. Administering LAABs as soon as possible after contracting COVID can also reduce symptom severity and risk of death.

 

He noted that the Ministry of Health has enough LAABs in stock for patients who need them, adding that the treatment is very safe. He also advised putting the current LAAB stock to use now while it remains effective.

 

Source: https://thainews.prd.go.th/en/news/detail/TCATG221214095839738

 

nnt.jpg
-- © Copyright NNT 2022-12-14
 

- Cigna offers a range of visa-compliant plans that meet the minimum requirement of medical treatment, including COVID-19, up to THB 3m. For more information on all expat health insurance plans click here.

 

Monthly car subscription with first-class insurance, 24x7 assistance and more in one price - click here to find out more!

If this worked, then give it to BIden, because his vaccinations did jack for him

Edited by RichardColeman

There was me thinking the headline was something to do with the food larb or however you spell it......:sorry:

Create an account or sign in to comment

Recently Browsing 0

  • No registered users viewing this page.

Account

Navigation

Search

Search

Configure browser push notifications

Chrome (Android)
  1. Tap the lock icon next to the address bar.
  2. Tap Permissions → Notifications.
  3. Adjust your preference.
Chrome (Desktop)
  1. Click the padlock icon in the address bar.
  2. Select Site settings.
  3. Find Notifications and adjust your preference.